Business description: Terumo Corporation

Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.

Number of employees: 30,591

Sales by Activity: Terumo Corporation

Fiscal Period: March 2021 (JPY) 2022 (JPY) 2023 (JPY) 2024 (JPY) 2025 (JPY)

Cardiac and Vascular Company

33TCr 40TCr 48TCr 56TCr 62TCr

Medical Care Solutions Company

18TCr 19TCr 19TCr 20TCr 21TCr

Blood and Cell Technologies Company

11TCr 12TCr 15TCr 17TCr 20TCr

Unallocated Adjustment

26Cr 25Cr 24Cr 25Cr 30Cr

Geographical breakdown of sales: Terumo Corporation

Fiscal Period: March 2021 (JPY) 2022 (JPY) 2023 (JPY) 2024 (JPY) 2025 (JPY)

United States

16TCr 19TCr 25TCr 28TCr 34TCr

Europe

12TCr 14TCr 16TCr 19TCr 22TCr

Japan

20TCr 21TCr 21TCr 21TCr 22TCr

Asia and Others

11TCr 7.7TCr 9.43TCr 11TCr 12TCr

China

- 5.94TCr 7.19TCr 7.94TCr 8.5TCr

Americas (Excluding United States)

2.29TCr 2.9TCr 4.05TCr 4.8TCr 5.28TCr

Executive Committee: Terumo Corporation

Manager TitleAgeSince
Chief Executive Officer 61 01/04/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - -
Compliance Officer 62 01/04/2024

Composition of the Board of Directors: Terumo Corporation

Director TitleAgeSince
Chairman 68 01/04/2022
Director/Board Member 63 21/06/2019
Director/Board Member 75 25/06/2020
Director/Board Member 73 22/06/2021
Director/Board Member 64 01/06/2021
Director/Board Member 61 01/04/2024
Director/Board Member 59 01/06/2024
Director/Board Member 62 01/06/2023
Director/Board Member 59 01/06/2024
Director/Board Member 65 -

Shareholders: Terumo Corporation

NameEquities%Valuation
Amova Asset Management Co., Ltd.
4.2 %
6,21,80,200 4.2 % 824 M ¥
Meiji Yasuda Life Insurance Co.
3.234 %
4,78,84,000 3.234 % 634 M ¥
BlackRock Fund Advisors
3.114 %
4,61,06,408 3.114 % 611 M ¥
2.69 %
3,98,27,000 2.69 % 528 M ¥
BlackRock Japan Co. Ltd.
2.299 %
3,40,34,300 2.299 % 451 M ¥
NameEquities%Valuation
State Street Global Advisors Europe Ltd.
0.002006 %
29,700 0.002006 % 393 525 ¥
Boston Common Asset Management LLC
0.001224 %
18,129 0.001224 % 240 209 ¥
RhumbLine Advisers LP
0.000905 %
13,393 0.000905 % 177 457 ¥
GAMMA Investing LLC
0.000359 %
5,309 0.000359 % 70 344 ¥
UBS Trust Company of Puerto Rico (Investment Management)
0.00014 %
2,066 0.00014 % 27 375 ¥

Holdings: Terumo Corporation

NameEquities%Valuation
54,87,400 0.37% 73 M $
5,30,000 6.41% 23 M $
1,22,080 0.17% 4 M $
2,79,200 0.01% 2 M $
84,692 0.04% 1 M $
1,40,368 0.58% 812 616 $
43,303 0.02% 799 699 $
50,000 0.16% 430 260 $
72,000 0.32% 371 563 $
1,050 0.01% 8 785 $

Company details: Terumo Corporation

Terumo Corp.

2-44-1 Hatagaya

151-0072, Tokyo

+81 3 3374 8111

https://www.terumo.co.jp
address Terumo Corporation(4543)

Group companies: Terumo Corporation

NameCategory and Sector
Miscellaneous Commercial Services
Miscellaneous Commercial Services
Medical Specialties
Medical Specialties
Terumo Europe NV (Belgium)

Other Medical Equipment, Supplies & Distribution

Change 5d. change 1-year change 3-years change Capi.($)
-1.49%-1.99%-21.82%+6.91% 1.98TCr
-0.74%-9.24%-30.02%-16.50% 16TCr
+1.17%-4.76%-0.50%-7.51% 11TCr
-2.25%-3.57%+6.98%+82.60% 6.08TCr
-1.02%-2.47%+83.76%+106.44% 6.1TCr
-0.87%-0.00%-22.20%-40.65% 4.46TCr
-1.15%-1.39% - - 3.86TCr
+0.51%+2.41%-4.98%-49.10% 2.42TCr
+1.55%+0.72%+0.15%+18.99% 2.15TCr
-2.39%+0.16%-5.40%-29.45% 2.16TCr
Average -0.67%-1.79%+0.66%+7.97% 5.59TCr
Weighted average by Cap. -0.56%-4.05%-1.98%+9.54%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,112.50JPY
Average target price
2,871.54JPY
Spread / Average Target
+35.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4543 Stock
  4. Company Terumo Corporation